English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Peptide Degrader-Based Targeting of METTL3/14 Improves Immunotherapy Response in Cutaneous Melanoma Journal article
Han, Hong, Li, Zenghui, Feng, Yuqing, Song, He, Fang, Zhixiong, Zhang, Dingxiao, Yuan, Dan, Shi, Junfeng. Peptide Degrader-Based Targeting of METTL3/14 Improves Immunotherapy Response in Cutaneous Melanoma[J]. Angewandte Chemie-International Edition, 2024, 63(48), e202407381.
Authors:  Han, Hong;  Li, Zenghui;  Feng, Yuqing;  Song, He;  Fang, Zhixiong; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:16.1/16.2 | Submit date：2024/11/05
Degradation  Immunotherapy  Melanoma  Mettl3  Peptide  
Comprehensive Characterization of the Integrin Family Across 32 Cancer Types Journal article
Zou, Cheng, Zhu, Jinwei, Xiong, Jiangling, Tian, Yu, Peng, Yousong, Cheung, Edwin, Zhang, Dingxiao. Comprehensive Characterization of the Integrin Family Across 32 Cancer Types[J]. Genomics Proteomics & Bioinformatics, 2024, 22(4), qzae035.
Authors:  Zou, Cheng;  Zhu, Jinwei;  Xiong, Jiangling;  Tian, Yu;  Peng, Yousong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:11.5/10.3 | Submit date：2024/12/05
Integrin  Pan-cancer  Tumor Microenvironment  Immunotherapy  Transcriptional Regulation